logo
  • Home
  • About
  • Activist Campaigns
  • Newsroom
  • ESG
  • Contact
  • Private Capital

News

ISS Recommends SpartanNash Shareholders Vote for Boardroom Change on Macellum and Ancora’s BLUE Proxy Card


by karl@kuraldesign.com

Macellum and Ancora File Definitive Proxy Statement and Send Letter to SpartanNash Shareholders


by karl@kuraldesign.com

Activists unpack SpartanNash


by karl@kuraldesign.com

SpartanNash gains after activists nominate directors, pushes for sale review (update)

March 18, 2022

Activist investor Macellum’s Duskin on fight with SpartanNash


by karl@kuraldesign.com

Activists Macellum, Ancora Pursue Board Fight at SpartanNash


by karl@kuraldesign.com

Macellum and Ancora Nominate Three Highly Qualified and Independent Candidates for Election to SpartanNash’s Board of Directors


by karl@kuraldesign.com

Macellum Nominates Ten Highly Qualified and Independent Candidates for Election to the Kohl’s Board of Directors

February 10, 2022

Kohl’s putting in a poison pill is unprecedented after only two weeks, says Macellum CEO


by karl@kuraldesign.com

Macellum Expresses Disappointment Regarding Kohl’s Seemingly Mismanaged and Poorly-Communicated Strategic Review Process

February 4, 2022

Recent Posts

  • ISS Recommends SpartanNash Shareholders Vote for Boardroom Change on Macellum and Ancora’s BLUE Proxy Card
  • Macellum and Ancora File Definitive Proxy Statement and Send Letter to SpartanNash Shareholders
  • Activists unpack SpartanNash
  • SpartanNash gains after activists nominate directors, pushes for sale review (update)
  • Activist investor Macellum’s Duskin on fight with SpartanNash

Recent Comments

No comments to show.

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • October 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • October 2019
  • May 2019
  • April 2019
  • March 2019
  • September 2017
  • May 2017
  • March 2016
  • May 2015
  • March 2015
  • November 2014

Categories

  • Commentary
  • News
  • Video
  • 1
  • 2
  • 3
  • …
  • 7

60 Broad Street
Suite 3825
New York, NY 10004

Quick Links

  • Home
  • About
  • Activist Campaigns
  • Newsroom
  • ESG
  • Contact

Macellum Advisors, LP, the investment adviser affiliate of Macellum Capital Management, is a Registered Investment Advisor regulated by the U.S. Securities and Exchange Commission (“SEC”) subject to the Rules and Regulations of the Investment Advisers Act of 1940. Registration with the SEC does not imply a certain level of skill or training.

© Macellum Capital Management. All rights reserved.